LifeSci Venture Partners
Website Molecule Banner.jpg

About Us

Passion. Experience. Diligence.


Formed in 2017, LifeSci Venture Partners is the early stage investing arm of LifeSci Partners, a unique life sciences and healthcare consultancy formed in 2010.  We focus on pre-public institutional rounds of transformational healthcare companies managed by exceptional founder/entrepreneurs.  Our investment principals have broad-ranging life sciences experience including public and private investing, deal structuring, investment banking, equity capital markets, equity research, and bench research - both basic science and applied.

Through our unique fund structure (domestic/offshore LP alongside co-investment SPV), we are able to close quickly and can structure a broad range of investment structures and sizes with typical check sizes between $1 million and $10 million.  We have a long term approach to investing and partnering with our portfolio companies.

Across our affiliated business units, we employ more than 90 experienced investment and science professionals, including 20+ PhDs and MDs in New York City, Boston, Philadelphia, London, Geneva, Paris and Tel Aviv.  We make the broad resources and expertise of our team available to our portfolio companies in helping them execute on their business plans and maximize shareholder value.

Our investment funds are separately managed from our client-facing businesses with a rigorous conflict clearance process to ensure objectivity in our investment decisions.  



Our Affiliates

LifeSci Advisors:  Comprehensive investor relations, customized marketing communications, and strategic counsel

LifeSci Public Relations:  Expert public and media relations support and strategic corporate communications counsel

LifeSci Search: Global executive recruitment specializing in C-Suite and board placements for the healthcare industry

LifeSci Capital: (member FINRA/SIPC):  Investment banking services including equity and debt issuance and product licensing advisory

BioShares ETFs:  Leading biotechnology exchange traded funds (NYSE: BBC & BBP